Extreme Longevity Clinical Trial
Official title:
Searching for Longevity Genes in the Historically Unique Ashkenazi Jewish Population
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of our research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
| Status | Recruiting |
| Enrollment | 1500 |
| Est. completion date | December 2027 |
| Est. primary completion date | December 2027 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 65 Years and older |
| Eligibility | Inclusion Criteria: - Ashkenazi Jewish, age 95+, - Offspring of person age 95+, - Offspring of parents who died age 70 or younger. Exclusion Criteria: - Non-Ashkenazis |
| Country | Name | City | State |
|---|---|---|---|
| United States | Boston University Medical Center | Boston | Massachusetts |
| United States | Private Homes | New York | New York |
| United States | Weill Cornell Medical College | New York | New York |
| United States | Hebrew Home Riverdale | Riverdale | New York |
| Lead Sponsor | Collaborator |
|---|---|
| Albert Einstein College of Medicine | American Federation for Aging Research, National Institute on Aging (NIA) |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06374069 -
Longevity Families of the Netherlands
|